全文获取类型
收费全文 | 66423篇 |
免费 | 5847篇 |
国内免费 | 4204篇 |
专业分类
耳鼻咽喉 | 627篇 |
儿科学 | 857篇 |
妇产科学 | 651篇 |
基础医学 | 5390篇 |
口腔科学 | 1220篇 |
临床医学 | 9175篇 |
内科学 | 7424篇 |
皮肤病学 | 841篇 |
神经病学 | 1973篇 |
特种医学 | 2051篇 |
外国民族医学 | 19篇 |
外科学 | 5233篇 |
综合类 | 15825篇 |
现状与发展 | 21篇 |
一般理论 | 1篇 |
预防医学 | 6683篇 |
眼科学 | 1194篇 |
药学 | 8002篇 |
96篇 | |
中国医学 | 5158篇 |
肿瘤学 | 4033篇 |
出版年
2024年 | 214篇 |
2023年 | 623篇 |
2022年 | 1724篇 |
2021年 | 2203篇 |
2020年 | 1908篇 |
2019年 | 1470篇 |
2018年 | 1460篇 |
2017年 | 1809篇 |
2016年 | 1490篇 |
2015年 | 2625篇 |
2014年 | 3410篇 |
2013年 | 3677篇 |
2012年 | 5648篇 |
2011年 | 6117篇 |
2010年 | 5161篇 |
2009年 | 4693篇 |
2008年 | 4919篇 |
2007年 | 4897篇 |
2006年 | 4599篇 |
2005年 | 3887篇 |
2004年 | 2841篇 |
2003年 | 2531篇 |
2002年 | 2074篇 |
2001年 | 1566篇 |
2000年 | 1245篇 |
1999年 | 877篇 |
1998年 | 522篇 |
1997年 | 521篇 |
1996年 | 362篇 |
1995年 | 301篇 |
1994年 | 310篇 |
1993年 | 170篇 |
1992年 | 134篇 |
1991年 | 109篇 |
1990年 | 97篇 |
1989年 | 57篇 |
1988年 | 54篇 |
1987年 | 53篇 |
1986年 | 38篇 |
1985年 | 27篇 |
1984年 | 8篇 |
1983年 | 5篇 |
1982年 | 7篇 |
1981年 | 4篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1974年 | 5篇 |
1972年 | 3篇 |
1970年 | 3篇 |
1936年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
2.
Noninvasive imaging of cardiac fibrosis is important for early diagnosis and intervention in chronic heart diseases. Here, we investigated whether noninvasive, contrast agent-free MRI T2-mapping can quantify myocardial fibrosis in preclinical models of aging and pressure overload. Myocardial fibrosis and remodeling were analyzed in two animal models: (i) aging (15-month-old male CF-1 mice vs. young 6- to 8-week-old mice), and (ii) pressure overload (PO; by transverse aortic constriction in 4- to 5-month-old male C57BL/6 mice vs. sham-operated for 14 days). In vivo T2-mapping was performed by acquiring data during the isovolumic and early diastolic phases, with a modified respiratory and ECG-triggered multiecho TurboRARE sequence on a 7-T MRI. Cine MRI provided cardiac morphology and function. A quantitative segmentation method was developed to analyze the in vivo T2-maps of hearts at midventricle, apex, and basal regions. The cardiac fibrosis area was analyzed ex vivo by picro sirius red (PSR) staining. Both aged and pressure-overloaded hearts developed significant myocardial contractile dysfunction, cardiac hypertrophy, and interstitial fibrosis. The aged mice had two phenotypes, fibrotic and mild-fibrotic. Notably, the aged fibrotic subgroup and the PO mice showed a marked decrease in T2 relaxation times (25.3 ± 0.6 in aged vs. 29.9 ± 0.7 ms in young mice, p = 0.002; and 24.3 ± 1.7 in PO vs. 28.7 ± 0.7 ms in shams, p = 0.05). However, no significant difference in T2 was detected between the aged mild-fibrotic subgroup and the young mice. Accordingly, an inverse correlation between myocardial fibrosis percentage (FP) and T2 relaxation time was derived (R2 = 0.98): T2 (ms) = 30.45 – 1.05 × FP. Thus, these results demonstrate a statistical agreement between T2-map–quantified fibrosis and PSR staining in two different clinically relevant animal models. In conclusion, T2-mapping MRI is a promising noninvasive contrast agent-free quantitative technique to characterize myocardial fibrosis. 相似文献
3.
4.
目的 分析新型冠状病毒肺炎(以下简称新冠肺炎)疫情对天津市无偿献血的影响.方法 回顾性分析该市2020年无偿献血人次及献血量,并与2019年献血情况进行对比;分析2020年春节前后及2019年同期的献血情况.结果 2020年捐献全血和单采血小板的总人次较2019年均下降13.03%,献血量分别下降17.60%、10.37%.2020年与2019年春节期间捐献全血和单采血小板的人次和献血量均明显下降,但2020年献血情况持续受疫情影响.2020年1-6月全血和单采血小板的献血情况较2019年同期下降较为明显,2020年7-12月的献血情况好转,与2019年同期差距减小.结论 新冠肺炎疫情对无偿献血工作提出严峻考验.常态化疫情防控期间,分析研判疫情对无偿献血工作的影响,有利于制订更有效的预防措施抗击疫情,保障临床用血. 相似文献
5.
目的对比不同术式对肝内胆管结石再次手术效果,探讨肝段或肝叶切除术的优势。
方法回顾性分析2011年8月至2014年8月收治的79例肝内胆管结石再次手术患者资料,依据术式不同分为肝段(叶)切除术组(甲组,n=38)和非肝段(叶)切除术组(乙组,n=41)两组。应用SPSS 19.0软件对所有临床数据进行统计学分析,手术相关指标等以(
±s)的形式表示,组间比较采用独立t检验;术后并发症发生情况及预后情况等计数资料以例(%)的形式表示,采用χ2检验;P<0.05差异有统计学意义。
结果两组患者术中出血量、手术时间及术后住院时间相比,差异无统计学意义(P>0.05);甲组患者的术后并发症发生率5.3%(2/38)显著低于乙组22.0%(9/41)(P<0.05);甲组残留结石发生率、症状复发率2.6%(1/38)、 0(0/41)均显著低于乙组17.1%(7/41)、 12.2%(5/41)(P<0.05),差异有统计学意义(P<0.05);但两组患者的病死率2.6%(1/38)和0(0/41)相比,差异无统计学意义(P>0.05)。
结论肝段(叶)切除术能够有效改善肝内胆管结石再次手术效果,值得推广。 相似文献
6.
7.
8.
9.
10.
OBJECTIVES: To assess the effectiveness and safety of additional bedtime H2‐receptor antagonists (H2RAs) in suppressing nocturnal gastric acid breakthrough (NAB) via a systematic review. METHODS: Eligible trials were identified by searching the Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library Issue 2, 2004), MEDLINE (January 1966–June 2004), EMBASE (January 1980–June 2004) and CINAHL (January 1982–June 2004). Additional hand‐searching was conducted on the proceedings of correlated conferences, eight important Chinese journals and references of all included trials. All randomized controlled trials evaluating H2RAs for the control of NAB were eligible for inclusion. The systematic review was conducted using methods recommended by The Cochrane Collaboration. RESULTS: Only two randomized crossover studies, comprising 32 participants, met the inclusion criteria. Because the design, dosage and duration of the treatments were different between the studies, it was not possible to conduct meta‐analysis. There were no consistent conclusions found between the two included studies in evaluating H2RAs for the control of NAB. CONCLUSIONS: No implications for practice at this stage can be concluded. Appropriately designed large‐scale randomized controlled trials with long‐term follow up are needed to determine the effects of additional bedtime H2RAs in suppressing NAB. 相似文献